Hsbc Holdings PLC Acquires 6,253 Shares of Addus HomeCare Corporation $ADUS

Hsbc Holdings PLC lifted its holdings in shares of Addus HomeCare Corporation (NASDAQ:ADUS) by 79.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 14,113 shares of the company’s stock after buying an additional 6,253 shares during the period. Hsbc Holdings PLC owned approximately 0.08% of Addus HomeCare worth $1,333,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the business. Capital Research Global Investors raised its position in Addus HomeCare by 22.3% in the 4th quarter. Capital Research Global Investors now owns 1,469,752 shares of the company’s stock worth $157,837,000 after buying an additional 268,192 shares during the last quarter. Vanguard Group Inc. grew its stake in shares of Addus HomeCare by 0.8% in the fourth quarter. Vanguard Group Inc. now owns 1,308,605 shares of the company’s stock worth $140,531,000 after acquiring an additional 10,501 shares during the period. Wasatch Advisors LP grew its stake in shares of Addus HomeCare by 0.8% in the third quarter. Wasatch Advisors LP now owns 936,243 shares of the company’s stock worth $110,467,000 after acquiring an additional 7,089 shares during the period. State Street Corp raised its holdings in shares of Addus HomeCare by 0.9% during the fourth quarter. State Street Corp now owns 702,229 shares of the company’s stock valued at $75,412,000 after purchasing an additional 6,561 shares during the last quarter. Finally, Dimensional Fund Advisors LP raised its holdings in shares of Addus HomeCare by 1.2% during the third quarter. Dimensional Fund Advisors LP now owns 667,256 shares of the company’s stock valued at $78,729,000 after purchasing an additional 7,884 shares during the last quarter. 95.35% of the stock is currently owned by institutional investors.

Addus HomeCare Stock Performance

Shares of NASDAQ ADUS opened at $115.65 on Tuesday. Addus HomeCare Corporation has a 12-month low of $87.95 and a 12-month high of $124.43. The firm has a market capitalization of $2.16 billion, a price-to-earnings ratio of 21.38, a price-to-earnings-growth ratio of 1.57 and a beta of 0.88. The company has a current ratio of 1.83, a quick ratio of 1.83 and a debt-to-equity ratio of 0.08. The firm has a 50 day moving average of $99.71 and a 200 day moving average of $101.23.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings results on Monday, May 4th. The company reported $1.62 earnings per share for the quarter, topping the consensus estimate of $1.52 by $0.10. The business had revenue of $363.50 million for the quarter, compared to the consensus estimate of $366.41 million. Addus HomeCare had a net margin of 6.89% and a return on equity of 9.80%. The company’s quarterly revenue was up 7.7% on a year-over-year basis. During the same period last year, the firm earned $1.42 earnings per share. On average, research analysts anticipate that Addus HomeCare Corporation will post 6.24 earnings per share for the current year.

Insider Activity at Addus HomeCare

In related news, insider Heather Brianne Dixon sold 288 shares of the firm’s stock in a transaction on Monday, June 22nd. The stock was sold at an average price of $93.77, for a total value of $27,005.76. Following the transaction, the insider directly owned 44,371 shares of the company’s stock, valued at approximately $4,160,668.67. This trade represents a 0.64% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 788 shares of company stock valued at $73,506. Corporate insiders own 4.10% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on ADUS shares. Citizens Jmp restated a “market outperform” rating and issued a $142.00 target price on shares of Addus HomeCare in a report on Monday, May 18th. Citigroup reiterated a “market outperform” rating on shares of Addus HomeCare in a research note on Friday. Barclays increased their price target on Addus HomeCare from $92.00 to $96.00 and gave the company an “underweight” rating in a report on Wednesday, July 8th. Finally, Weiss Ratings upgraded Addus HomeCare from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, July 9th. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, Addus HomeCare currently has an average rating of “Moderate Buy” and an average target price of $131.50.

Addus HomeCare Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.